Published on 5/4/2017 in the Prospect News Structured Products Daily.
New Issue: Barclays prices $12.31 million phoenix autocallables on three funds
By Wendy Van Sickle
Columbus, Ohio, May 4 – Barclays Bank plc priced $12.31 million of phoenix autocallable notes due May 2, 2019 linked to the lesser performing of the iShares Nasdaq Biotechnology ETF, the Financial Select Sector SPDR Fund and the Technology Select Sector SPDR Fund, according to a 424B2 filing with the Securities and Exchange Commission.
Each quarter, the notes will pay a contingent coupon at a rate of 10% per year if each fund closes at or above its barrier level, 75% of its initial level, on the observation date for that quarter.
The notes will be automatically called at par plus the contingent coupon if each fund closes at or above its initial level on any quarterly observation date.
If each fund finishes at or above its barrier level, the payout at maturity will be par. Otherwise, investors will lose 1% for each 1% decline of the least-performing fund.
Barclays is the agent.
| Issuer: | Barclays Bank plc
|
| Issue: | Phoenix autocallable notes
|
| Underlying funds: | iShares Nasdaq Biotechnology ETF, Financial Select Sector SPDR Fund and Technology Select Sector SPDR Fund
|
| Amount: | $12,306,000
|
| Maturity: | May 2, 2019
|
| Coupon: | Each quarter, notes pay contingent coupon at rate of 10% per year if each fund closes at or above barrier level on observation date for that quarter; otherwise, no coupon paid that quarter
|
| Price: | Par
|
| Payout at maturity: | Par plus final contingent coupon, if any, unless any fund finishes below its barrier level, in which case 1% loss for every 1% that lesser-performing index finishes below initial level
|
| Call: | Automatically at par plus contingent coupon if each fund closes at or above initial level on any coupon observation date
|
| Initial index levels: | $54.38 for Technology, $23.53 for Financial and $297.64 for Biotech
|
| Barrier levels: | $40.79 for Technology, $17.65 for Financial and $223.23 for Biotech; 75% of initial levels
|
| Pricing date: | April 28
|
| Settlement date: | May 3
|
| Agent: | Barclays
|
| Fees: | 1.75%
|
| Cusip: | 06741VSZ6
|
|
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
